WinstonWınston
Fresenius Medical Care AG & Co. KGaA logo

Fresenius Medical Care AG & Co. KGaA

FMS
54
Medical - Care Facilities · Healthcare
Price
$24.11
+0.02 (+0.08%)
Market Cap
$12.95B
Exchange
New York Stock Exchange
Winston Score
54
Winston is curious
Mixed quality — meaningful strengths and weaknesses.

Share count falling — buybacks

50.3% over 4y

The company has reduced its share count over this period, returning value to shareholders through buybacks.

Diluted shares outstanding: 1.17B (2021) → 582.4M (2025)

Fresenius Medical Care is the world's largest provider of kidney dialysis services and equipment. It runs thousands of dialysis clinics where patients with kidney failure come in several times a week to have their blood cleaned by machines. The company also makes and sells the dialysis machines, filters, and fluids used in those treatments.

Fresenius Medical Care earns money two ways: by charging patients and insurers for dialysis treatments at its clinics, and by selling dialysis products to hospitals and other care providers. It operates in over 40 countries, with a large portion of revenue coming from the United States, where government programs like Medicare pay for most dialysis care. Its size gives it a cost advantage, but the business faces real pressure from U.S. reimbursement rate changes, since government decisions about how much to pay per treatment directly affect how much money the company makes.

Winston Score History

Score breakdown

Every number that matters to educated investors.

Each metric is explained in plain language so you know exactly what you're looking at. Start your free trial now.

Quality

Gross Margin
25.6%
Modest — 25.6% gross margin
Operating Margin
8.1%
Modest — 8.1% operating margin
ROCE
1.8%
Weak — 1.8% return on capital

ROIC between 0% and 5%. They earn a few cents back per dollar invested in the business.

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Growth

Sales YoY
-0.7%
Shrinking sales (-0.7% YoY)
EPS YoY
+146.3%
Earnings growing fast (146.3% YoY)

Earnings growing 25%+ a year. The compounder zone.

EPS Consistency
6/8 quarters
Earnings grew in most of the last 8 quarters

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Cash Flow

Cash Conversion
288%
Turns 288% of profit into real cash
FCF Margin
9.1%
Modest free cash flow (9.1%)

FCF margin between 0% and 10%. Some cash from sales, but not a lot.

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Stability

Debt / Equity
0.57
Conservative — low debt load (0.57)
Interest Cover
4.77x
Adequate interest coverage (4.8x)

Interest coverage between 3 and 8. Profits cover interest several times over.

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Valuation

P/E Ratio (TTM)
14.6x
Attractive valuation — P/E 14.6

P/E in the normal range. Price is roughly $15 for every $1 of yearly profit.

P/E vs Forward
+5.1
GROWING
Earnings expected to grow meaningfully — cheaper on forward P/E (14.6 → 9.5)

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Dividends

Dividend Yield
3.63%
Moderate income — 3.63% yield

Standard yield zone for stable dividend payers. A meaningful piece of total return.

Dividend Growth
+0.9%
Dividend flat

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free
🔒 See full fundamentals and if they are improving or declining — click here for your free trial now.
Start free trial